Cargando…
Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy
BACKGROUND: Thyroid-associated ophthalmopathy (TAO) is a common and organ-specific autoimmune disease. Early diagnosis and novel treatments are essential to improve the prognosis of TAO patients. Therefore, the current work was performed to identify the key genes and pathways for the biological and...
Autores principales: | Wang, Yueyue, Shao, Yanfei, Zhang, Haitao, Wang, Jun, Zhang, Peng, Zhang, Weizhong, Chen, Huanhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440526/ https://www.ncbi.nlm.nih.gov/pubmed/36056316 http://dx.doi.org/10.1186/s12864-022-08854-5 |
Ejemplares similares
-
Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study
por: Wang, Yueyue, et al.
Publicado: (2023) -
Leptin receptor is a key gene involved in the immunopathogenesis of thyroid‐associated ophthalmopathy
por: Chen, Ziyi, et al.
Publicado: (2021) -
Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022) -
Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017) -
Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023)